Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers (Q70089819)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

M D Schaller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J Nussberger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

B Waeber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J P Bussien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

G A Turini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

H Brunner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

H R Brunner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

267-272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00543322

8 October 2019

exact match

0 references

cites work

Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures

1 reference

12 December 2020

Measurement of concentrations of angiotensin I in human blood by radioimmunoassay

1 reference

12 December 2020

The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril

1 reference

12 December 2020

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

12 December 2020

CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers

1 reference

12 December 2020

RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers

1 reference

12 December 2020

Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure

1 reference

12 December 2020

A specific orally active inhibitor of angiotensin-converting enzyme in man.

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521): disposition in man

1 reference

12 December 2020

The Effect of Captopril on Blood Pressure and Angiotensins I, II and III in Sodium-Depleted Dogs: Problems Associated with the Measurement of Angiotensin II after Inhibition of Converting Enzyme

1 reference

12 December 2020

A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers

1 reference

12 December 2020

Long-term control of congestive heart failure with captopril

1 reference

12 December 2020

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

1 reference

12 December 2020

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition in congestive heart failure: The concept

1 reference

12 December 2020

Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states.

1 reference

12 December 2020

Improvement of chronic congestive heart-failure by oral captopril

1 reference

12 December 2020

Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade

1 reference

12 December 2020

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

12 December 2020

Long-term clinical experience with enalapril in essential hypertension

1 reference

12 December 2020

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

12 December 2020

Captopril in the treatment of clinical hypertension and cardiac failure

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00543322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2988972%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference